2013
DOI: 10.1007/s00232-013-9563-6
|View full text |Cite
|
Sign up to set email alerts
|

The Pathogenic A391E Mutation in FGFR3 Induces a Structural Change in the Transmembrane Domain Dimer

Abstract: Fibroblast growth factor receptor 3 (FGFR3) is a single-pass membrane protein and a member of the receptor tyrosine kinase family of proteins that is involved in the regulation of skeletal growth and development. FGFR3 has three distinct domains: the ligand binding extracellular domain, the cytosolic kinase domain and the transmembrane domain (TMD). Previous work with the isolated FGFR3 TMD has shown that it has the ability to dimerize. Clinical and genetic studies have also correlated mutations in the TMD wit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 30 publications
0
4
0
Order By: Relevance
“…We scanned the PilO transmembrane and found that there is a conserved Small-xxx-Small motif present at residues 40 and 44 (A40xxxA44). This motif has been shown to play an important role in helix-helix dimerization in transmembrane proteins (22,23); thus, we hypothesized that this domain might be mediating interaction between the α-helix of PilO and the SadC TMD. To identify mutations in the A40xxxA44 motif of PilO that impact PilO-SadC interaction, we used two different approaches.…”
Section: Resultsmentioning
confidence: 99%
“…We scanned the PilO transmembrane and found that there is a conserved Small-xxx-Small motif present at residues 40 and 44 (A40xxxA44). This motif has been shown to play an important role in helix-helix dimerization in transmembrane proteins (22,23); thus, we hypothesized that this domain might be mediating interaction between the α-helix of PilO and the SadC TMD. To identify mutations in the A40xxxA44 motif of PilO that impact PilO-SadC interaction, we used two different approaches.…”
Section: Resultsmentioning
confidence: 99%
“…Since there have been no case reports describing the patients who had the p.L377R or the p.S378N variant independently, we do not know whether these variants are pathogenic or not. A previous in vitro study by ToxR plasmids carrying the FGFR3 transmembrane domain demonstrated that the substitutions of the p.S378 to glycine, alanine, cysteine, or isoleucine showed no or very little changes in the dimerization of the receptor (Mudumbi, Julius, Herrmann, & Li, ), although the effect of the p.S378N was not examined. They also demonstrated that p.S378I significantly altered the dimerization propensity of the receptor with the p.A391E, which is a pathogenic mutation causing Crouzon syndrome with acanthosis nigricans.…”
Section: Discussionmentioning
confidence: 99%
“…Another interesting case is variant c.1172C>A (p.A391E). It is located in the transmembrane domain of the receptor and has been described to lead to constitutive receptor activation already in the absence of ligand (Chen et al, 2011; Mudumbi et al, 2013; Sarabipour and Hristova, 2016). We observed the same effect when measuring the GRB2 recruitment and we also showed that this variant cannot be further triggered by the addition of ligand.…”
Section: Discussionmentioning
confidence: 99%